• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征女性的母亲、父亲、姐妹和兄弟的代谢综合征、高血压和高脂血症:系统评价和荟萃分析。

Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.

机构信息

Department of Obstetrics and Gynecology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey.

Division of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, Atlanta, Georgia.

出版信息

Fertil Steril. 2018 Feb;109(2):356-364.e32. doi: 10.1016/j.fertnstert.2017.10.018. Epub 2018 Jan 11.

DOI:10.1016/j.fertnstert.2017.10.018
PMID:29331234
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5983376/
Abstract

OBJECTIVE

To provide an evidence-based assessment of metabolic syndrome, hypertension, and hyperlipidemia in first-degree relatives of women with polycystic ovary syndrome (PCOS).

DESIGN

Systematic review and meta-analysis.

SETTING

Not applicable.

PATIENT(S): Mothers, fathers, sisters, and brothers of women with and without PCOS.

INTERVENTION(S): An electronic-based search with the use of PubMed from 1960 to June 2015 and cross-checked references of relevant articles.

MAIN OUTCOME MEASURE(S): Metabolic syndrome, hypertension and dyslipidemia, and surrogate markers, including systolic blood pressure (BP), diastolic BP, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides.

RESULT(S): Fourteen of 3,346 studies were included in the meta-analysis. Prevalence of the following was significantly increased in relatives of women with PCOS: metabolic syndrome (risk ratio [RR] 1.78 [95% confidence interval 1.37, 2.30] in mothers, 1.43 [1.12, 1.81] in fathers, and 1.50 [1.12, 2.00] in sisters), hypertension (RR 1.93 [1.58, 2.35] in fathers, 2.92 [1.92, 4.45] in sisters), and dyslipidemia (RR 3.86 [2.54, 5.85] in brothers and 1.29 [1.11, 1.50] in fathers). Moreover, systolic BP (mothers, sisters, and brothers), total cholesterol (mothers and sisters), low-density lipoprotein cholesterol (sisters), and triglycerides (mothers and sisters) were significantly higher in first-degree relatives of PCOS probands than in controls.

CONCLUSION(S): Our results show evidence of clustering for metabolic syndrome, hypertension, and dyslipidemia in mothers, fathers, sisters, and brothers of women with PCOS.

SYSTEMATIC REVIEW REGISTRATION NUMBER

PROSPERO 2016 CRD42016048557.

摘要

目的

对多囊卵巢综合征(PCOS)患者的一级亲属中的代谢综合征、高血压和高脂血症进行基于证据的评估。

设计

系统评价和荟萃分析。

设置

不适用。

患者

有和没有 PCOS 的女性的母亲、父亲、姐妹和兄弟。

干预措施

从 1960 年到 2015 年 6 月,使用基于电子的 PubMed 搜索,并交叉检查相关文章的参考文献。

主要观察指标

代谢综合征、高血压和血脂异常以及替代标志物,包括收缩压(BP)、舒张压、总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇和甘油三酯。

结果

在 3346 项研究中,有 14 项被纳入荟萃分析。患有 PCOS 的女性的亲属中,以下疾病的患病率显著增加:代谢综合征(母亲为 1.78 [95%置信区间 1.37,2.30],父亲为 1.43 [1.12,1.81],姐妹为 1.50 [1.12,2.00])、高血压(父亲为 1.93 [1.58,2.35],姐妹为 2.92 [1.92,4.45])和血脂异常(兄弟为 3.86 [2.54,5.85],父亲为 1.29 [1.11,1.50])。此外,一级亲属的收缩压(母亲、姐妹和兄弟)、总胆固醇(母亲和姐妹)、低密度脂蛋白胆固醇(姐妹)和甘油三酯(母亲和姐妹)均显著高于对照组。

结论

我们的研究结果表明,在患有 PCOS 的女性的母亲、父亲、姐妹和兄弟中,代谢综合征、高血压和血脂异常存在聚集现象。

系统评价注册号

PROSPERO 2016 CRD42016048557。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b0d/5983376/b7cfd59f0a38/nihms964526f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b0d/5983376/374d808723b2/nihms964526f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b0d/5983376/b7cfd59f0a38/nihms964526f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b0d/5983376/374d808723b2/nihms964526f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b0d/5983376/b7cfd59f0a38/nihms964526f2.jpg

相似文献

1
Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征女性的母亲、父亲、姐妹和兄弟的代谢综合征、高血压和高脂血症:系统评价和荟萃分析。
Fertil Steril. 2018 Feb;109(2):356-364.e32. doi: 10.1016/j.fertnstert.2017.10.018. Epub 2018 Jan 11.
2
Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征女性的母亲、父亲、姐妹和兄弟的糖尿病和胰岛素抵抗:系统评价和荟萃分析。
Fertil Steril. 2018 Aug;110(3):523-533.e14. doi: 10.1016/j.fertnstert.2018.04.024. Epub 2018 Jun 28.
3
Adolescent PCOS and long-term metabolic risk: insights from triglycerides to high-density lipoprotein cholesterol ratio and high-density lipoprotein cholesterol profiles.青少年多囊卵巢综合征与长期代谢风险:从甘油三酯与高密度脂蛋白胆固醇比值及高密度脂蛋白胆固醇谱获得的见解
Front Endocrinol (Lausanne). 2025 Jun 3;16:1579217. doi: 10.3389/fendo.2025.1579217. eCollection 2025.
4
Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome.多囊卵巢综合征女性姐妹中的血脂异常和代谢综合征
J Clin Endocrinol Metab. 2005 Aug;90(8):4797-802. doi: 10.1210/jc.2004-2217. Epub 2005 May 17.
5
The Association Between Polycystic Ovary Syndrome and Metabolic Syndrome in Adolescents: a Systematic Review and Meta-analysis.多囊卵巢综合征与青少年代谢综合征的相关性:系统评价和荟萃分析。
Reprod Sci. 2023 Jan;30(1):28-40. doi: 10.1007/s43032-022-00864-8. Epub 2022 Feb 2.
6
Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.二甲双胍是否能改善非肥胖型多囊卵巢综合征不孕妇女的生殖结局?荟萃分析和系统评价。
Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:38-62. doi: 10.1016/j.ejogrb.2022.01.025. Epub 2022 Feb 1.
7
High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.多囊卵巢综合征女性一级男性亲属中代谢综合征的高发与肥胖率高有关。
J Clin Endocrinol Metab. 2009 Nov;94(11):4361-6. doi: 10.1210/jc.2009-1333. Epub 2009 Oct 16.
8
Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis.性激素结合球蛋白——预测多囊卵巢综合征风险的重要生物标志物:一项系统评价和荟萃分析
Syst Biol Reprod Med. 2018 Feb;64(1):12-24. doi: 10.1080/19396368.2017.1410591. Epub 2017 Dec 11.
9
Gonadotropins for ovulation induction in women with polycystic ovary syndrome.用于多囊卵巢综合征女性促排卵的促性腺激素。
Cochrane Database Syst Rev. 2025 Apr 7;4(4):CD010290. doi: 10.1002/14651858.CD010290.pub4.
10
Polycystic Ovary Syndrome, Metabolic Syndrome, and Inflammation in the Hispanic Community Health Study/Study of Latinos.西班牙裔社区健康研究/拉丁裔研究中的多囊卵巢综合征、代谢综合征与炎症
J Clin Endocrinol Metab. 2025 Apr 22;110(5):1384-1397. doi: 10.1210/clinem/dgae426.

引用本文的文献

1
Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches.心脏代谢疾病中的性别二态性:从发育到衰老及治疗方法
Cells. 2025 Mar 20;14(6):467. doi: 10.3390/cells14060467.
2
Polycystic ovary syndrome as a metabolic disease.多囊卵巢综合征作为一种代谢性疾病。
Nat Rev Endocrinol. 2025 Apr;21(4):230-244. doi: 10.1038/s41574-024-01057-w. Epub 2024 Nov 28.
3
Decreased AMPK/SIRT1/PDK4 induced by androgen excess inhibits human endometrial stromal cell decidualization in PCOS.雄激素过多导致的 AMPK/SIRT1/PDK4 减少抑制了 PCOS 中人类子宫内膜基质细胞的蜕膜化。

本文引用的文献

1
Epigenetics and a new look on metabolic syndrome.表观遗传学与代谢综合征新视角。
Physiol Res. 2015;64(5):611-20. doi: 10.33549/physiolres.933174.
2
Prevalence of the metabolic syndrome in the United States, 2003-2012.2003 - 2012年美国代谢综合征的患病率。
JAMA. 2015 May 19;313(19):1973-4. doi: 10.1001/jama.2015.4260.
3
Genetic testing in hyperlipidemia.高脂血症的基因检测
Cell Mol Life Sci. 2024 Jul 30;81(1):324. doi: 10.1007/s00018-024-05362-5.
4
Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.通过通路富集分析和枢纽基因- microRNA网络揭示多囊卵巢综合征(PCOS)的关键生物标志物和治疗药物
Iran J Pharm Res. 2023 Nov 20;22(1):e139985. doi: 10.5812/ijpr-139985. eCollection 2023 Jan-Dec.
5
Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS).诱导多能干细胞在探索多囊卵巢综合征(PCOS)病理生理学中的可能应用。
Stem Cell Rev Rep. 2024 Jan;20(1):67-87. doi: 10.1007/s12015-023-10627-w. Epub 2023 Sep 28.
6
Integrated bioinformatics analysis elucidates granulosa cell whole-transcriptome landscape of PCOS in China.中国多囊卵巢综合征患者颗粒细胞全转录组的综合生物信息学分析。
J Ovarian Res. 2023 Aug 3;16(1):154. doi: 10.1186/s13048-023-01223-0.
7
Analyzing the Impact of FSHR Variants on Polycystic Ovary Syndrome-a Case-Control Study in Punjab.分析 FSHR 变异对多囊卵巢综合征的影响——旁遮普邦的病例对照研究。
Reprod Sci. 2023 Aug;30(8):2563-2572. doi: 10.1007/s43032-023-01194-z. Epub 2023 Feb 23.
8
Correlation of Markers of Inflammation with Hormonal, Metabolic Parameters, Insulin Resistance and Adiposity Indices in First-Degree Relatives of Patient with Polycystic Ovary Syndrome.多囊卵巢综合征患者一级亲属中炎症标志物与激素、代谢参数、胰岛素抵抗及肥胖指数的相关性
J Hum Reprod Sci. 2022 Jul-Sep;15(3):250-258. doi: 10.4103/jhrs.jhrs_104_22. Epub 2022 Sep 30.
9
The Effect of High Intensity Intermittent and Combined (Resistant and Endurance) Trainings on Some Anthropometric Indices and Aerobic Performance in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial Study.高强度间歇训练与联合(抗阻和耐力)训练对多囊卵巢综合征女性某些人体测量指标和有氧能力的影响:一项随机对照临床试验研究。
Int J Fertil Steril. 2022 Oct 1;16(4):268-274. doi: 10.22074/ijfs.2022.551096.1279.
10
Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia.家族性高胆固醇血症中遗传和非遗传心血管危险因素的临床方面。
Genes (Basel). 2022 Jun 27;13(7):1158. doi: 10.3390/genes13071158.
Cardiol Clin. 2015 May;33(2):267-75. doi: 10.1016/j.ccl.2015.02.006.
4
Hypertension.高血压。
Lancet. 2015 Aug 22;386(9995):801-12. doi: 10.1016/S0140-6736(14)61468-9. Epub 2015 Mar 29.
5
Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India.印度北部多囊卵巢综合征女性家庭成员中代谢综合征的患病率。
Indian J Endocrinol Metab. 2014 May;18(3):364-9. doi: 10.4103/2230-8210.131186.
6
Family background of Diabetes Mellitus, obesity and hypertension affects the phenotype and first symptom of patients with PCOS.糖尿病、肥胖症和高血压的家族史影响多囊卵巢综合征患者的表型和首发症状。
Gynecol Endocrinol. 2013 Dec;29(12):1040-4. doi: 10.3109/09513590.2013.829446. Epub 2013 Oct 8.
7
Cardiometabolic aspects of the polycystic ovary syndrome.多囊卵巢综合征的心脏代谢方面。
Endocr Rev. 2012 Oct;33(5):812-41. doi: 10.1210/er.2012-1003. Epub 2012 Jul 24.
8
Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.多囊卵巢综合征在不同诊断标准下的流行情况、表型及心血管代谢风险。
Hum Reprod. 2012 Oct;27(10):3067-73. doi: 10.1093/humrep/des232. Epub 2012 Jul 9.
9
Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.多囊卵巢综合征患者女儿在不同 Tanner 期的抗苗勒管激素(AMH)与胰岛素水平的关系。
Reprod Sci. 2012 Apr;19(4):383-90. doi: 10.1177/1933719111424444. Epub 2012 Feb 16.
10
Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women.多囊卵巢综合征妇女的青春期前和青春期女儿血清脂肪细胞衍生蛋白与胰岛素敏感性和生殖特征的关系。
Eur J Obstet Gynecol Reprod Biol. 2012 Mar;161(1):56-61. doi: 10.1016/j.ejogrb.2011.12.012. Epub 2012 Jan 23.